Status:
COMPLETED
Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.
Lead Sponsor:
Thomas Jefferson University
Conditions:
Migraine
Eligibility:
All Genders
18-65 years
Brief Summary
Cutaneous allodynia (pronounced q-tane-ee-us all-o-din-ee-a) is common in migraine. It is a heightened skin sensitivity during an active migraine attack. Migraine attacks in patients who experience al...
Eligibility Criteria
Inclusion
- Male and female patients aged 18-65, inclusive
- Diagnosis of episodic migraine with or without aura.
- Ability to read and understand an informed consent form and study procedures
Exclusion
- Patients with abnormal sensory findings on examination, or any known neurological disease that may affect skin sensation (peripheral neuropathy, multiple sclerosis, stroke, etc).
- Patients who suffer from headache (of any type) 15 or more days per month
- Patients who are cognitively impaired, as determined by investigator
- Patients with significant psychiatric disorder that may affect their understanding of the study protocol and/or their cooperation with the investigators.
- Patients who had taken any acute pain medication (e.g. triptans, ergots, NSAIDs, opioids, butalbital, acetaminophen) for any indication within 12 hours prior to allodynia testing.
- Patients with skin diseases that may cause abnormal skin sensation.
- Patients who had been treated with a nerve block in the 4 week period prior to allodynia testing Patients who had been treated with Botulinum neurotoxin within the 4 month period prior to allodynia testing
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00329771
Start Date
March 1 2006
End Date
March 1 2008
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jefferson Headache Center
Philadelphia, Pennsylvania, United States, 19107